US Stock MarketDetailed Quotes

Orchestra BioMed (OBIO)

Watchlist
  • 4.170
  • -0.290-6.50%
Close Jan 15 16:00 ET
  • 4.220
  • +0.050+1.20%
Post 20:01 ET
235.46MMarket Cap-2.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Orchestra BioMed (OBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
-46.74%620K
-21.88%2.76M
-76.25%262K
Operating revenue
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
-46.74%620K
-21.88%2.76M
-76.25%262K
Cost of revenue
-27.94%49K
4.55%46K
29.41%44K
9.68%204K
23.40%58K
65.85%68K
-18.52%44K
-22.73%34K
-11.85%186K
-11.32%47K
Gross profit
-11.64%812K
7.63%790K
40.61%824K
-5.44%2.43M
-9.30%195K
143.12%919K
-14.75%734K
-47.68%586K
-22.52%2.57M
-79.52%215K
Operating expense
22.39%21.13M
14.35%20.12M
31.55%19.75M
23.40%66.74M
32.89%16.87M
15.83%17.26M
27.33%17.59M
18.51%15.01M
50.31%54.08M
16.71%12.7M
Selling and administrative expenses
25.27%7.1M
-3.14%6.26M
6.21%6.26M
18.13%23.93M
41.00%5.9M
-10.69%5.67M
21.61%6.47M
33.69%5.9M
44.35%20.26M
25.49%4.19M
Research and development costs
20.97%14.03M
24.51%13.85M
47.96%13.48M
26.56%42.8M
28.90%10.97M
35.49%11.6M
30.91%11.13M
10.39%9.11M
54.12%33.82M
12.83%8.51M
Operating profit
-24.30%-20.31M
-14.64%-19.33M
-31.19%-18.92M
-24.84%-64.3M
-33.62%-16.68M
-12.52%-16.34M
-30.13%-16.86M
-24.93%-14.42M
-57.72%-51.51M
-26.99%-12.48M
Net non-operating interest income expense
-156.22%-515K
-103.99%-36K
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
14.80%1.02M
7,598.00%3.85M
136.25%1.11M
Non-operating interest income
----
----
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
14.80%1.02M
7,598.00%3.85M
--1.11M
Total other finance cost
156.22%515K
103.99%36K
----
----
----
---916K
---902K
----
----
----
Other net income (expense)
94.60%-79K
0
25.81%-23K
80.00%-56K
-46.15%-1.46M
-269.57%-1.45M
Gain on sale of security
----
----
----
78.21%-68K
--0
----
25.81%-23K
83.93%-45K
2.19%-312K
24.81%-294K
Special income (charges)
----
----
----
--0
----
----
----
----
-68.77%-1.15M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
68.77%1.15M
----
Other non- operating income (expenses)
----
----
----
---11K
--0
----
----
---11K
----
----
Income before tax
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
Income tax
Net income
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
Net income continuous Operations
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
Minority interest income
Net income attributable to the parent company
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
Basic earnings per share
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
Diluted earnings per share
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K-46.74%620K-21.88%2.76M-76.25%262K
Operating revenue -12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K-46.74%620K-21.88%2.76M-76.25%262K
Cost of revenue -27.94%49K4.55%46K29.41%44K9.68%204K23.40%58K65.85%68K-18.52%44K-22.73%34K-11.85%186K-11.32%47K
Gross profit -11.64%812K7.63%790K40.61%824K-5.44%2.43M-9.30%195K143.12%919K-14.75%734K-47.68%586K-22.52%2.57M-79.52%215K
Operating expense 22.39%21.13M14.35%20.12M31.55%19.75M23.40%66.74M32.89%16.87M15.83%17.26M27.33%17.59M18.51%15.01M50.31%54.08M16.71%12.7M
Selling and administrative expenses 25.27%7.1M-3.14%6.26M6.21%6.26M18.13%23.93M41.00%5.9M-10.69%5.67M21.61%6.47M33.69%5.9M44.35%20.26M25.49%4.19M
Research and development costs 20.97%14.03M24.51%13.85M47.96%13.48M26.56%42.8M28.90%10.97M35.49%11.6M30.91%11.13M10.39%9.11M54.12%33.82M12.83%8.51M
Operating profit -24.30%-20.31M-14.64%-19.33M-31.19%-18.92M-24.84%-64.3M-33.62%-16.68M-12.52%-16.34M-30.13%-16.86M-24.93%-14.42M-57.72%-51.51M-26.99%-12.48M
Net non-operating interest income expense -156.22%-515K-103.99%-36K-83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K14.80%1.02M7,598.00%3.85M136.25%1.11M
Non-operating interest income ---------83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K14.80%1.02M7,598.00%3.85M--1.11M
Total other finance cost 156.22%515K103.99%36K---------------916K---902K------------
Other net income (expense) 94.60%-79K025.81%-23K80.00%-56K-46.15%-1.46M-269.57%-1.45M
Gain on sale of security ------------78.21%-68K--0----25.81%-23K83.93%-45K2.19%-312K24.81%-294K
Special income (charges) --------------0-----------------68.77%-1.15M----
-Less:Other special charges --------------------------------68.77%1.15M----
Other non- operating income (expenses) ---------------11K--0-----------11K--------
Income before tax -35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M
Income tax
Net income -35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M
Net income continuous Operations -35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M
Minority interest income
Net income attributable to the parent company -35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M
Basic earnings per share 2.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.455.00%-0.38-39.22%-1.48-19.97%-0.37
Diluted earnings per share 2.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.455.00%-0.38-39.22%-1.48-19.97%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -